An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and preliminary effectiveness of the
novel compound RWJ-333369 in patients with partial onset seizures who are currently being
treated with 1 or 2 concomitant antiepileptic drugs.